Roddie, C., Dias, J., O'Reilly, M. A., Abbasian, M., Cadinanos-Garai, A., Vispute, K., Bosshard-Carter, L., Mitsikakou, M., Mehra, V., Roddy, H., Hartley, J. A., Spanswick, V., Lowe, H., Popova, B., Clifton-Hadley, L., Wheeler, G., Olejnik, J., Bloor, A., Irvine, D., Wood, L., Marzolini, M. A. V., Domning, S., Farzaneh, F., Lowdell, M. W., Linch, D. C., Pule, M. A., & Peggs, K. S. (2021). durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Journal of clinical oncology, 39(30), 3352–3363. http://access.bl.uk/ark:/81055/vdc_100150609950.0x00002a